http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1691752-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3f0c7feda9ae4e172309b7da622f9fa |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-534 |
| filingDate | 1988-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1991-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_104ec522aa4ff937c79bde457199aaa4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f41d11e61b3e39caffaf182100abb1a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed609df7afb8d71755189563d4b08bce |
| publicationDate | 1991-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1691752-A1 |
| titleOfInvention | Method for evaluation of rheumatoid arthritis treatment effectiveness |
| abstract | The invention relates to medicine, primarily rheumatology, and can be used to evaluate the effectiveness of treatment for rheumatoid arthritis. The aim of the invention is to improve the accuracy of the assessment. This is achieved by examining the patient's blood with the determination of calcitonin parameters before and for 15–16 minutes with calcium gluconate solution, and with a ratio of 3.6 and above, a positive treatment effect is determined, and with a ratio of less than 3.6 determine the low efficacy of the treatment and correct it. The invention reduces the likelihood of error in the assessment from 25.8 to 8.1% and below. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8790714-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009074889-A1 |
| priorityDate | 1988-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.